One World Products, Inc. Files S-1 Registration Statement

TL;DR

<b>One World Products, Inc. has filed an S-1 registration statement with the SEC.</b>

AI Summary

One World Products, Inc. (OWPC) filed a IPO Registration (S-1) with the SEC on January 23, 2024. One World Products, Inc. (OWPC) filed an S-1 registration statement with the SEC on January 23, 2024. The company was formerly known as One World Pharma, Inc. and PUNTO GROUP, CORP. The filing indicates a fiscal year end of December 31st. The company's principal business address is in Las Vegas, Nevada. The SIC code for the company is Pharmaceutical Preparations [2834].

Why It Matters

For investors and stakeholders tracking One World Products, Inc., this filing contains several important signals. This S-1 filing is a crucial step for One World Products, Inc. as it signals their intent to potentially offer securities to the public, which could lead to significant capital infusion or liquidity events. The historical name changes suggest a period of restructuring or strategic shifts, and the S-1 filing will provide updated details on the company's current business operations and future plans.

Risk Assessment

Risk Level: low — One World Products, Inc. shows low risk based on this filing. The filing is an S-1 registration statement, which is a preliminary step and does not contain detailed financial performance data or operational results that would indicate immediate risk.

Analyst Insight

Monitor future filings from One World Products, Inc. for details on the proposed offering and financial performance.

Key Numbers

• 2024-01-23 — Filing Date (Date of S-1 filing)
• 1231 — Fiscal Year End (Company's fiscal year end)
• 2019-01-25 — Name Change Date (Date of former name change to One World Pharma, Inc.)
• 2014-10-14 — Name Change Date (Date of former name change to PUNTO GROUP, CORP.)

Key Players & Entities

• One World Products, Inc. (company) — Filer name
• OWPC (company) — Ticker symbol
• S-1 (regulator) — Form type
• SEC (regulator) — Filing agency
• One World Pharma, Inc. (company) — Former company name
• PUNTO GROUP, CORP. (company) — Former company name
• Las Vegas, Nevada (location) — Business address state
• 2834 (industry) — Standard Industrial Classification

Forward-Looking Statements

• One World Products, Inc. will proceed with a public offering of securities to raise capital. (One World Products, Inc.) — high confidence, target: 2024-12-31
• The offering will likely involve the issuance of common stock, potentially leading to dilution for existing shareholders. (One World Products, Inc.) — medium confidence, target: 2024-12-31

FAQ

Industry Context

One World Products, Inc. operates within the Pharmaceutical Preparations industry, which involves the manufacturing of drugs and medicines.

Regulatory Implications

The filing is subject to the regulations of the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933.

What Investors Should Do

1. Review the full S-1 filing for detailed information on the company's business, financials, and proposed offering.
2. Track future SEC filings from One World Products, Inc. for updates on their public offering status.
3. Research the company's historical performance and market position within the pharmaceutical preparations sector.

Key Dates

• 2024-01-23: S-1 Filing — Registration statement filed with the SEC.

Glossary

S-1

A registration statement filed with the U.S. Securities and Exchange Commission (SEC) by companies planning to offer securities to the public. (Indicates the company's intent to go public or raise capital through securities offerings.)

SIC Code

Standard Industrial Classification code used to classify industries. (Helps categorize the company's primary business activity within the pharmaceutical preparations sector.)

Year-Over-Year Comparison

This is an initial S-1 filing, so there is no prior filing to compare against for financial or operational changes.

Key Financial Figures

• $0.0527 — ary 2, 2024, our common stock closed at $0.0527 per share. These are speculative secu
• $1.2 million — ligations to creditors of approximately $1.2 million during the Reorganization Proceedings.
• $3,000,000 — s the sole member, Mr. Thomas purchased $3,000,000 of our Series B Preferred Stock in inst
• $10,000,000 — Tysadco has committed to purchase up to $10,000,000 of our common stock upon our delivery o
• $25,000 — greement will be in a minimum amount of $25,000 and a maximum amount equal to the lesse
• $1,000,000 — ximum amount equal to the lesser of (i) $1,000,000 and (ii) 500% of the average daily trad
• $1,513,374 — 022 and 2021, we incurred net losses of $1,513,374, $3,059,477 and $3,784,562, respectivel
• $3,059,477 — , we incurred net losses of $1,513,374, $3,059,477 and $3,784,562, respectively. As of suc
• $3,784,562 — et losses of $1,513,374, $3,059,477 and $3,784,562, respectively. As of such dates, we had
• $24,489,739 — h dates, we had accumulated deficits of $24,489,739, $22,976,365 and $19,916,888, respectiv
• $22,976,365 — ad accumulated deficits of $24,489,739, $22,976,365 and $19,916,888, respectively. We expec
• $19,916,888 — eficits of $24,489,739, $22,976,365 and $19,916,888, respectively. We expect our losses to
• $1.2 m — financial obligations of approximately $1.2 million, which are substantially past due

Filing Documents

• forms-1.htm (S-1) — 3390KB
• ex23-1.htm (EX-23.1) — 4KB
• ex107.htm (EX-FILING FEES) — 12KB
• forms-1_001.jpg (GRAPHIC) — 10KB
• forms-1_02.jpg (GRAPHIC) — 8KB
• ex23-1_001.jpg (GRAPHIC) — 13KB
• 0001493152-24-003504.txt (&nbsp;) — 14499KB
• owpc-20230930.xsd (EX-101.SCH) — 96KB
• owpc-20230930_cal.xml (EX-101.CAL) — 102KB
• owpc-20230930_def.xml (EX-101.DEF) — 481KB
• owpc-20230930_lab.xml (EX-101.LAB) — 596KB
• owpc-20230930_pre.xml (EX-101.PRE) — 585KB
• forms-1_htm.xml (XML) — 2741KB

USE OF PROCEEDS

USE OF PROCEEDS 12 PLAN OF DISTRIBUTION 14 MARKET FOR OUR COMMON STOCK 15 DIVIDEND POLICY 15

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 16 DESCRIPTION OF OUR BUSINESS 24 DESCRIPTION OF PROPERTY 29

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 29

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 29 MANAGEMENT 32 DISCLOSURE OF COMMISSION POSITION ON INDEMNIFICATION FOR SECURITIES LIABILITIES 35 LEGAL MATTERS 35 EXPERTS 36 AVAILABLE INFORMATION 36 i ABOUT THIS PROSPECTUS You should rely only on the information contained in or incorporated by reference in this prospectus. We have not authorized any person to provide you with different or inconsistent information. If anyone provides you with different or inconsistent information, you should not rely on it. This is not an offer to sell or seeking an offer to buy these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus and the documents incorporated by reference is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may have changed since such dates. We further note that the representations, warranties and covenants made by us in any document that is filed as an exhibit to the registration of the parties to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed to be a representation, warranty or covenant to you. Moreover, such representations, warranties or covenants were accurate only as of the date when made. Accordingly, such representations, warranties and covenants should not be relied on as accurately representing the current state of our affairs. Unless the context otherwise requires, the terms "One World Products", the "Company", "we", "us", "our" and similar terms used in this prospectus refer to One World Products, Inc. and its subsidiaries, including One World Pharma SAS, a Colombian company. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This prospectus and the docum

View Full Filing

View this S-1 filing on SEC EDGAR